Current status of Radiation Oncology Facilities in Nigeria

Main Article Content

Dr. Sunday Adeyemi Adewuyi
Oladapo Babatunde Campbell
Kingsley Kayode Ketiku
Francis Abayomi Duronsinmi-Etti
Josbat Thomas Kofi-Duncan
Philip Chinedu Okere

Abstract

Background: An analysis of the current radiation oncology facilities status in Nigeria was conducted to establish a comprehensive baseline. Nigeria is the most populated African country with a population of at least 160 million people based on 2006 population census and average annual growth rate of 3.1%. It is also one of the least developed countries as regards radiation oncology resources with inadequate radiotherapy facilities. Many of the patients have little or no access to safe and modern radiation therapy.


Purpose: To obtain a better understanding of the status of radiation oncological practices in Nigeria and to help sensitize the Nigerian government and its developmental partners on the way forward.


Materials and Methods: The data were obtained mainly through surveys on the availability of major items of equipment and personnel which were conducted in September 2011. The study included only commissioned and functioning public radiotherapy facilities which are 5 in the country. Data were related to number and types of megavoltage machines, trained manpower (Radiation Oncologists, Medical Physicists, Oncology Nurses, Radiotherapy technologists, maintenance engineers and mould room Technicians), treatment planning systems TPS, Brachytherapy equipment, CT Simulator and Conventional simulators.


Results: Of over 50 Tertiary Health Institutions (Teaching Hospitals and Federal Medical Centers) in the country, only 5 has Radiation Therapy facilities with 1 megavoltage machine each, 2 located in the north, 2 in the south and 1 in the Federal Capital Territory. The population served by each megavoltage machine ranges from 20 to 40 million per machine based on 2006 census. Most patients have little or no access to radiation oncology services. Some differences in equipment and personnel amongst centers were demonstrated and the shortage of radiation therapy resources was grossly evident. There are 18 Radiation Oncologists, 8 Medical physicists, 18 Radiotherapy technologists, 26 Oncology Nurses, 3 linear accelerators, 2 Co-60 machines, 2 orthovoltage therapy machines, 2 conventional simulators, 2 CT simulators, 2 centers with 3D TPS, 3 LDR and 1 HDR brachytherapy machines and 2 mould rooms. Some centers were found to treat patients without simulators or treatment planning system.


Conclusion: A large deficiency exists for radiation oncological services in Nigeria. There are significant deficiencies in the availability of all components of radiation therapy in the analysed centers. Cognisance should be taken of the specific short falls in each centre to ensure that there is expansion of existing centers and creation of new centers especially in every geopolitical zone and major teaching hospitals in the country.

Downloads

Download data is not yet available.

Article Details

Section

Original Article

How to Cite

Adewuyi, S. A., Campbell, O. B., Ketiku, K. K., Duronsinmi-Etti, F. A., Kofi-Duncan, J. T., & Okere, P. C. (2025). Current status of Radiation Oncology Facilities in Nigeria. West African Journal of Radiology, 20(1), 30-36. https://doi.org/10.82235/wajr.vol20no1.232

References

1. Hanson GP, Stjernsward J, Nofal M, Durosinmi‑Etti F. An overview of the situation in radiotherapy with emphasis on the developing

countries. Int J Radiat Oncol Biol Phys 1990;19:1257‑61.

2. Nofal M, Durosinmi‑Etti F, Hanson GP, Stjernsward J. Supporting cancer care in the developing countries: Role of IAEA/WHO. Int J

Radiat Oncol Biol Phys 1990;19:1249‑56.

3. Salmineh E, Izekska J, Andreo P. IAEA’s role in the global management of cancer: Focus on upgrading radiotherapy services.

Acta Oncol 2005;44:816‑24.

4. Durosinmi‑Etti F, Nofal M, Mahfouz MM. Radiotherapy in Africa: Current needs and prospects. IAEA Bull 1991;4:24‑8.

5. Barton MB, Frommer M, Shafiq J. Role of radiotherapy in cancer control in low‑income and middle‑income countries. Lancet Oncol

2006;7:584‑95.

6. Levin CV, El Gueddari B, Meghzifene A. Radiation therapy in Africa: Distribution and equipment. Radiother Oncol 1999;52:79‑84.

7. Adewuyi SA, Arogundade R, Igashi JB, Chom ND, Hamidu AU, Campbell OB. The pattern of chest radiographs findings in

metastatic cancer patients seen in a tertiary hospital in northern Nigeria. Niger Postgrad Med J 2011;18:245‑50.

8. Abdel‑Wahab M, Rosenblatt E, Holmberg O, Meghzifene A. Safety in radiation oncology: The role of international initiatives by the International Atomic Energy Agency. J Am Coll Radiol 2011;8:789‑94.

9. Owen JB, Coia LR, Hanks GE. The structure of radiation oncology in the United States in 1994. Int J Radiat Oncol Biol Phys 1997; 39:179‑85.

10. Goksel F, Koc O, Ozgul N, Gultekin M, Abacioglu M, Tuncer M, et al. Radiation oncology facilities in Turkey: Current status and

future perspectives. Asian Pac J Cancer Prev 2011;12:2157‑62.

11. Wigg DR, Morgan GW. Radiation oncology in Australia: Workforce, workloads and equipment 1986‑1999. Australas Radiol

2001;45:146‑69.

12. Numasaki H, Teshima T, Shibuya H, Nishio M, Ikeda H, Ito H, et al. National structure of radiation oncology in Japan with special

reference to designated cancer care hospitals. Int J Clin Oncol 2009;14:237‑44.

13. Ruggieri‑Pignon S, Pignon T, Marty M, Rodde‑Dunet MH, Destembert B, Fritsch B. Infrastructure of radiation oncology in France: A large survey of evolution of external beam radiotherapy practice. Int J Radiat Oncol Biol Phys 2005;61:507‑16.

14. Palacios Eito A, Espinosa Calvo M, Manas Rueda A, de Las Heras M. Radiation oncology: Future needs and equipment. Current situation in Spain. Clin Transl Oncol 2008;10:478‑85.

15. International Atomic Energy Agency. Setting up a Radiotherapy Programme: Clinical, Medical Physics, Radiation Protection and

Safety Aspects. Vienna: International Atomic Energy Agency; 2008. p. 6‑45.

16. International basic safety standards for protection against ionizing radiation and for the safety of radiation sources, safety. Vienna: International Atomic Energy Agency; 1996, Series no. 115.

17. Report: National Council on Radiation Protection and Measurements. Structural shielding design and evaluation for

megavoltage X‑ and gamma‑ray radiotherapy facilities. Bethesda, MD: National Council on Radiation Protection and Measurements;

2005, Report no.:151.

18. Borras C, Stovall J. Report: Design requirements for megavoltage X ray machines for cancer treatment in developing countries,

report of an advisory group consultation. Los Alamos: Los Alamos National Lab; 1993, La‑ur‑95‑4528.

19. International Atomic Energy Agency. Organization and Implementation of a National Regulatory Infrastructure Governing

Protection Against Ionizing Radiation and the Safety of Radiation Sources. Vienna: IAEA; 1999, IAEA‑TECDOC‑1067.

20. Zaidi H. Medical physics in developing countries: Looking for a better world. Biomed Imaging Interv J 2008;4:e29.

21. Belletti S, Dutreix A, Garavaglia G, Gfirtner H, Haywood J, Jessen KA, et al. Quality assurance in radiotherapy: The importance of medical physics staffing levels. Recommendations from an ESTRO/EFOMP joint task group. Radiother Oncol 1996;41:89‑94.

22. Shortt K, Davidsson L, Hendry J, Dondi M, Andreo P. International perspectives on quality assurance and new techniques in radiation medicine: Outcomes of an IAEA conference. Int J Radiat Oncol Biol Phys 2008;71 (1 Suppl):S80‑4.

23. Thwaites D, Scalliet P, Leer JW, Overgaard J. Quality assurance in radiotherapy. European Society for Therapeutic Radiology and

Oncology Advisory Report to the Commission of the European Union for the ‘Europe Against Cancer Programme’. Radiother Oncol 1995;35:61‑73.

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.